558 reports of this reaction
1.6% of all VALBENAZINE reports
#17 most reported adverse reaction
ADVERSE DRUG REACTION is the #17 most commonly reported adverse reaction for VALBENAZINE, manufactured by Neurocrine Biosciences, Inc.. There are 558 FDA adverse event reports linking VALBENAZINE to ADVERSE DRUG REACTION. This represents approximately 1.6% of all 34,810 adverse event reports for this drug.
Patients taking VALBENAZINE who experience adverse drug reaction should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ADVERSE DRUG REACTION is a less commonly reported adverse event for VALBENAZINE, but still significant enough to appear in the safety profile.
In addition to adverse drug reaction, the following adverse reactions have been reported for VALBENAZINE:
The following drugs have also been linked to adverse drug reaction in FDA adverse event reports:
ADVERSE DRUG REACTION has been reported as an adverse event in 558 FDA reports for VALBENAZINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ADVERSE DRUG REACTION accounts for approximately 1.6% of all adverse event reports for VALBENAZINE, making it a notable side effect.
If you experience adverse drug reaction while taking VALBENAZINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.